1932 ⎘
Rearing or breeding animals, not otherwise provided for; New breeds of animals; New breeds of vertebrates Chimeric animals, e.g. comprising exogenous cells
Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics
#302Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis
#303Animal models and therapeutic molecules
#304Genetically modified non-human animals and methods relating to innate immune system response detection
#305Non-human animals having a disruption in a C9ORF72 locus
#306Population of isolated chicken cells reprogrammed from somatic cells
#307ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#308Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#309Methods and compositions for generating a mouse
#310ES Cell-Derived Mice From Diploid Host Embryo Injection
#311TRANSGENIC BIRDS THAT PRODUCE CHIMERIC HUMAN IMMUNOGLOBULINS
#312Gene therapy to prevent reactions to allergens
#313Genetically modified non-human animals and methods of use thereof
#314Light-sensitive ion-passing molecules
#315Method for producing pluripotent stem cell having improved chimera forming ability from primed pluripotent stem cell, and composition and combination therefor
#316Methods of generating mature human muscle fibers
#317Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
#318Immune competent models of human disease
#319Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#320Mouse model for engraftment potential
#321Method for regenerating hair follicles using CD36-expressing dermal sheath cells
#322Method For Creating Endometriotic Cells And Endometriosis Model Animal
#323Stem cells for modeling type 2 diabetes
#324GENETICALLY MODIFIED RAT MODELS FOR PHARMACOKINETICS
#325Immune-compromised zebrafish
#326MODEL OF COLORECTAL CANCER
#327Dosage compensating transgenes and cells
#328HUMANIZED MOUSE MODEL FOR STUDY OF BONA FIDE HEPATITIS VIRUS INFECTION AND USE THEREOF
#329Methods for treatment comprising an antibody that binds CD223 protein
#330RECOMBINANT NON-HUMAN MAMMALIAN MODEL FOR HEPATITIS INFECTION AND IMMUNOPATHOGENESIS
#331Means and methods for treating cancer
#332METHOD FOR PRODUCING CHIMERIC ANIMAL
#333Systems and methods for preclinical models of metastases
#334Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#335GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE
#336Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy
#337Genetically modified non-human animals expressing human EPO
#338RECONSTITUTED HUMAN IMMUNE SYSTEM IN A PATIENT DERIVED XENOGRAFT MOUSE MODEL
#339ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM
#340Method of establishing isogenic multi-xenograft model and the use thereof
#341Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor
#342Hybrid baculovirus and uses thereof
#343Methods of reprogramming animal somatic cells
#344Genetically modified non-human animals and methods of use thereof
#345Obesity animal model and methods for making and using thereof
#346Autologous Mammalian Models Derived from Induced Pluripotent Stem Cells and Related Methods
#347Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereof
#348Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#349CANCER STEM CELLS AND METHODS OF USING THE SAME
#350Reducing immunogenicity of xenogeneic transplant tissues
#351Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
#352HLA G-modified cells and methods
#353Compounds and methods for altering RSV replication rate
#354NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE
#355Cell line of renal sarcomatoid carcinoma in persons of Han nationality and preparation method thereof
#356TUMOR-INITIATING CELLS AND METHODS OF USE
#357Pterygium animal model using human pterygial epithelial cells
#358Urokinase-type plasminogen activator transgenic mouse
#359METHODS OF INCREASING THE NUMBER OF TARGET CELLS RECOVERED FROM A FLUID SAMPLE
#360Genetically modified non-human animals and methods relating to innate immune system response detection
#361Method for preparing patient-specific glioblastoma animal model, and uses thereof
#362METHOD FOR ENHANCING TUMOR GROWTH
#363Method for culturing avian gonocytes
#364Method of making a chicken with germ cells expressing marker protein
#365Non-invasive in vivo imaging and methods for treating type I diabetes
#366Transgenic immunodeficient mouse expressing human SIRP-alpha
#367Humanized M-CSF mice
#368Genetically modified major histocompatibility complex mice
#369Animal models and therapeutic molecules
#370TL1A model of inflammation fibrosis and autoimmunity
#371Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#372Production and use of rat spermatogonial stem cell lines
#373Methods and compositions for generating a mouse
#374Method for treating psoriasis
#375Isolated populations of female germline stem cells and cell preparations and compositions thereof
#376XENOGRAFT MODEL OF HUMAN BONE METASTATIC PROSTATE CANCER
#377Production of a human beta cell line from an early post natal pancreas
#378Composition for a mitotic remodeling of chromosomes
#379Inhibition of oncogenic kras-induced GM-CSF production and function
#380GPR15-mediated homing and uses thereof
#381Method for producing model animal, and model animal
#382Production and use of red blood cells
#383Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder
#384Chimeric non-human animal carrying human hepatocyte
#385GERMLINE TRANSMISSION OF AVIAN PRIMORDIAL GERM CELLS (PGCS)
#386Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver
#387Boosting human dendritic cell development, homeostasis and function in xenografted immunodeficient mice
#388Animal models and therapeutic molecules
#389Animal models and therapeutic molecules
#390Generation of autologous T-cells in mice
#391Tumor model system useful to study multistage cancer
#392Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#393METHOD OF CONSTRUCTING ANIMAL HAVING CANCER CELLS TRANSPLANTED THEREINTO
#394METHOD FOR THE TREATMENT OR PROPHYLAXIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM) AND ANIMAL MODEL FOR USE IN LAM RESEARCH
#395Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#396Method for treating cancer using an antibody that inhibits notch4 signaling
#397BIOMARKERS AND THEIR USES IN CANCER DETECTION AND THERAPY
#398Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
#399Compositions and methods for characterizing and treating muscular dystrophy
#400Method to enhance delivery of glutathione and ATP levels in cells
#401ANIMAL MODEL FOR THE EVALUATION OF THE EFFICACY OF AN HIV VACCINE
#402Compositions and methods relating to non-human animals modified to promote production of selected gametes
#403Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain
#404Method of establishing mouse strain
#405Compositions and methods to control angiogenesis with cupredoxins
#406Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor
#407Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof
#408Chimeric avian-based screening system containing mammalian grafts
#409Rodent Therapeutic Model And Methods
#410Genetically modified major histocompatibility complex mice
#411Methods of enhancing pluripotentcy
#412Method for treating cancer with an antibody to CD223 protein
#413Light-sensitive ion-passing molecules
#414Light-sensitive ion-passing molecules
#415Method for treating psoriasis
#416Identification and Enrichment of Cell Subpopulations
#417Identification and Enrichment of Cell Subpopulations
#418CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof
#419Transgenic mouse homozygous for chimeric IgH locus
#420Humanized M-CSF mice
#421Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs
#422Genetically modified mice and engraftment
#423PROTEIN FRAGMENT COMPLEMENTATION ASSAYS FOR THE DETECTION OF BIOLOGICAL OR DRUG INTERACTIONS
#424Genetically modified mice and engraftment
#425Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein
#426Light-sensitive ion-passing molecules
#427MEANS AND METHODS FOR IMPROVING THE DEVELOPMENT AND MATURATION OF EGGS AND/OR SPERM IN FISH USING HORMONES PRODUCED BY TRANSPLANTED CELLS
#428Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection
#429Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
#430Prospective Identification and Characterization of Breast Cancer Stem Cells
#431Stem Cell Fusion Model of Carcinogenesis
#432REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN
#433Method of inducing cellular growth and materials for use therewith
#434Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant
#435Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
#436MicroRNA as a cancer progression predictor and its use for treating cancer
#437Transgenic mice expressing human toll-like receptor 8
#438Non-Human Mammal Model Of Human Hematopoietic Cancer
#439Method for Generating Immune-Compatible Cells and Tissues Using Nuclear Transfer Techniques
#440Implantable human liver tissue constructs and uses thereof
#441HUMANISED PSORIASIS MODEL
#442ANIMAL MODELS AND THERAPEUTIC MOLECULES
#443DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#444METHODS AND COMPOSITIONS FOR CELL THERAPY
#445Compositions and methods to control angiogenesis with cupredoxins
#446METHODS FOR ESTABLISHING SYMBIOSES
#447ADULT ANIMALS GENERATED FROM INDUCED PLURIPOTENT CELLS
#448Compositions and methods relating to non-human animals modified to promote production of selected gametes
#449ANIMAL MODELS AND THERAPEUTIC MOLECULES
#450Methods Of Producing Humanized Non-Human Mammals
#451SYNTHETIC GRAFT
#452Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#453Animal Model for Toxicology and Dose Prediction
#454CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
#455ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#456TRUNCATED ACTIVIN TYPE II RECEPTOR AND METHODS OF USE
#457BOOSTING HUMAN DENDRITIC CELL DEVELOPMENT, HOMEOSTASIS AND FUNCTION IN XENOGRAFTED IMMUNODEFICIENT MICE
#458Method for obtaining female germline stem cells and uses thereof
#459Methods for producing microRNAs
#460TL1A model of inflammation fibrosis and autoimmunity
#461Chromosome 3p21.3 genes are tumor suppressors
#462Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
#463Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
#464PREVENTION AND TREATMENT OF BLOOD COAGULATION-RELATED DISASES
#465Humanized NSG mouse, method of producing the same and use thereof
#466Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#467METHOD OF EXPANDING HUMAN HEPATOCYTES IN VIVO
#468Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#469Determining the capability of a test compound to affect solid tumor stem cells
#470Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
#471Production and use of rat spermatogonial stem cell lines
#472MODIFIED ORGANS AND CELLS FOR XENOTRANSPLANTATION
#473PRODUCTION OF PROTEINS IN EGGS
#474Protein fragment complementation assays for the detection of biological or drug interactions
#475METHODS FOR INTRODUCING HETEROLOGOUS CELLS INTO FISH
#476METHOD FOR EVALUATION OF DIFFERENTIATION ABILITY OF STEM CELL
#477THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#478ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#479ALLOGENEIC VACCINE AND METHODS TO SYNTHESIZE SAME
#480Liver engrafting cells, assays, and uses thereof
#481Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#482MODELS OF ERYTHROPOIESIS
#483PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
#484TRANSGENIC ANIMALS AND USES THEREOF
#485Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer
#486ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#487Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#488Genetically modified mice and engraftment
#489Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37
#490Sustained culture of avian gonocytes
#491Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
#492ADULT BONE MARROW CELL TRANSPLANTATION TO TESTES CREATION OF TRANSDIFFERENTIATED TESTES GERM CELLS, LEYDIG CELLS AND SERTOLI CELLS
#493ECTOPIC, ORTHOTOPIC MODEL FOR REVASCULARIZATION AND TUMOR ASSESSMENT
#494Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
#495Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection
#496ALLOGENEIC VACCINE AND METHODS TO SYNTHESIZE SAME
#497Method for modifying chromosomes
#498Genetically Modified Rat Models for Pharmacokinetics
#499Methods of Reprogramming Animal Somatic Cells
#500Tumor model system useful to study multistage cancer
#501USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA
#502COMPOSITIONS AND METHODS FOR DERIVING OR CULTURING PLURIPOTENT CELLS
#503Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#504Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#505METHOD FOR PRODUCING FOUNDER ANIMAL FOR REPRODUCING ANIMAL HAVING LETHAL PHENOTYPE CAUSED BY GENE MODIFICATION
#506Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis
#507Method for the treatment of lymphangioleiomyomatosis (LAM)
#508Truncated activin type II receptor and methods of use
#509PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS
#510IMAGEABLE RODENT MODEL OF ASTHMA
#511METHODS FOR IDENTIFICATION AND SELECTION OF HUMAN EMBRYONIC STEM CELL DERIVED CELLS
#512RECOMBINANT NEWCASTLE DISEASE VIRUS
#513METHOD FOR REPROGRAMMING IN VITRO STEM CELLS AND SOMATIC CELLS INTO GERMINAL CELLS
#514Production of human antibodies using NOD/SCID/γmice
#515Methods and compositions for mitochondrial replacement therapy
#516METHOD OF PREPARING INDUCED PLURIPOTENT STEM CELLS DEPRIVED OF REPROGRAMMING GENE
#517STEM CELLS FOR USE IN LOCATING AND TARGETING TUMOR CELLS
#518Methods of using human tissue factor-producing knock-in mice
#519Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide
#520Method of expanding human hepatocytes in vivo
#521Treatment of squamous cell carcinoma with HSP27 antisense oligonucleotides and radiotherapy
#522Combination Immunogene Therapy
#523TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT
#524NEURAL TUMOR STEM CELLS AND METHODS OF USE THEREOF
#525WNT PATHWAY MUTATIONS IN CANCER STEM CELLS
#526MODELS FOR VACCINE ASSESSMENT
#527Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
#528ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS
#529Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#530METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#531Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles
#532Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
#533Production of Proteins in Eggs
#534METHODS AND COMPOSITIONS TO TREAT ARRHYTHMIAS
#535Use of a cellular extract for a mitotic remodeling of chromosomes
#536Methods of Reprogramming Animal Somatic Cells
#537Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#538Tumor-initiating cells and methods of use
#539Reduction of graft-versus-host disease by modulation of SHIP activity
#540Transgenic chickens with an inactivated endogenous gene locus
#541Transgenic pig as a model of Alzheimer's disease
#542Pig model for atherosclerosis
#543METHOD OF PRODUCING A MULTICHIMERIC MOUSE AND APPLICATIONS TO STUDY THE IMMUNOPATHOGENESIS OF HUMAN TISSUE-SPECIFIC PATHOLOGIES
#544METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
#545Organ regeneration method utilizing blastocyst complementation
#546Xenogenic immune system in a non-human mammal
#547Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#548PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX
#549Methods for Assessing the Delivery of Exogenous Agents
#550Oncolytic Adenoviruses and Uses Thereof
#551Erythropoietin-Producing Organoid Precursor, Production Method Thereof, and Method For Treating Erythropoietin-Related Disorder
#552Cancer Compositions, Animal Models, and Methods of Use Thereof
#553GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS
#554ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL
#555Transgenic non-human animals expressing a truncated activin type II receptor
#556CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereof
#557Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery
#558Prion-free transgenic ungulates
#559IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES
#560Bioactive scaffolds
#561Compositions and methods to control angiogenesis with cupredoxins
#562MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS
#563Nonalcoholic steatohepatitis model rodent and fatty liver model rodent
#564ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS
#565Anti-IL-6 antibodies, compositions, methods and uses
#566SGRF gene-modified mouse
#567Production of ungulates, preferably bovines that produce human immunoglobulins
#568ES Cell-Derived Mice From Diploid Host Embryo Injection
#569Isolated human chromosome 14 fragment encoding immunoglobulin genes
#570Methods for identifying neuripotent cells
#571RNAi Therapeutics for Treatment of Eye Neovascularization Diseases
#572Chemical inhibitors of inhibitors of differentiation
#573Method of producing xenogenous antibodies using a bovine
#574Cell-based RNA interference and related methods and compositions
#575Diabetes Model Animal
#576Non-human animal sarcoma model
#577Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
#578Transgenic Mammals Expressing Human Preproinsulin
#579Anti-Neovasculature Preparations for Cancer
#580Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#581Model for studying the role of genes in chemoresistance
#582Truncated Activin Type II Receptor and Methods of Use
#583Method For Preparing An Organ For Transplantation
#584Composition and method for imaging cells
#585Novel Method for Generating Non-Human ES Animals
#586Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells
#587Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy
#588Transgenic bovine having reduced prion protein activity and uses thereof
#589DIRECTED COMPLEMENTATION WITH REMOVABLE GENE OF INTEREST
#590Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection
#591Chimeric Non-Human Animal and Use Thereof
#592ANIMAL MODEL FOR HEPATITIS C VIRUS INFECTION
#593Methods and compositions for cell therapy
#594Method for Preparing Cell Fraction Containing Hemangioblasts
#595PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#596ISOLATION AND TRANSPLANTATION OF RETINAL STEM CELLS
#597Cell lines and animal models of HER2 expressing tumors
#598Method for Identifying Within a Mammal a DNA encoding a Physiologically Active Polypeptide
#599Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
#600Production of Proteins in Eggs